Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInventory AverageInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Bluejay Diagnostics (BJDX) Equity Ratio (2020 - 2026)

Bluejay Diagnostics' Equity Ratio history spans 3 years, with the latest figure at 0.59 for Q4 2023.

  • On a quarterly basis, Equity Ratio fell 30.34% to 0.59 in Q4 2023 year-over-year; TTM through Dec 2023 was 0.59, a 30.34% decrease, with the full-year FY2023 number at 0.59, down 30.34% from a year prior.
  • Equity Ratio hit 0.59 in Q4 2023 for Bluejay Diagnostics, down from 0.63 in the prior quarter.
  • Over the last five years, Equity Ratio for BJDX hit a ceiling of 0.97 in Q4 2021 and a floor of 0.59 in Q4 2023.
  • Historically, Equity Ratio has averaged 0.82 across 3 years, with a median of 0.85 in 2022.
  • The widest YoY moves for Equity Ratio: up 8.6% in 2023, down 30.34% in 2023.
  • Tracing BJDX's Equity Ratio over 3 years: stood at 0.97 in 2021, then dropped by 11.98% to 0.85 in 2022, then plummeted by 30.34% to 0.59 in 2023.
  • Business Quant data shows Equity Ratio for BJDX at 0.59 in Q4 2023, 0.63 in Q3 2023, and 0.75 in Q2 2023.